Expression of Interleukin-21 and -23 in Human Esophageal Tumors Produced Antitumor Effects in Nude Mice

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 79-82

  Shan, Baoen ^a,b   Yu, Ling ^a   Shimozato, Osamu ^a   Li, Qiaoxia ^a,b   Tagawa, Masatoshi ^a  

^a CHIBA CANCER CENTER   (Japan)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal tumors; Gene therapy; IL 21; IL 23

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 21; INTERLEUKIN 23; PROTEIN P19; PROTEIN P40; RETROVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; ESOPHAGUS TUMOR; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR REGRESSION;

ANIMALS; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; GENE THERAPY; HUMANS; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; MICE; MICE, INBRED C3H; MICE, NUDE; TRANSDUCTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 1442277104     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tepper RI and Mulé JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Human Gene Ther 5: 153-164, 1994.
2. Tagawa M: Cytokine therapy for cancer. Curr Pharm Des 6: 681-699, 2000.
3. Abbas AK, Murphy KM and Sher A: Functional diversity of helper T lymphocytes. Nature 283: 787-793, 1996.
4. Parrish-Novok J, Dillon SR, Nelson A et al: Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63, 2000.
5. Ozaki K, Kikly K, Michalovich D, Young PR and Leonard WJ: Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain. Proc Natl Acad Sci USA 97: 11439-11444, 2000.
6. Kasaian MT, Whitters MJ, Carter LL et al: IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16: 559-569, 2002.
7. Oppmann B, Lesley R, Blom B et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725, 2000.
8. Parham C, Chirica M, Timans J et al: A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168: 5699-5708, 2002.
9. Miller AD and Rosman GJ: Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-990, 1989.
10. Duke GM, Hoffman MA and Palmenberg AC: Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J Virol 66: 1602-1609, 1992.
11. Matsubara H, Koide Y, Sugaya M, Gunji Y, Asano T, Ochiai T, Takenaga K, Sakiyama S and Tagawa M: Antitumor response of genetically engineered IL-2 expression to human esophageal carcinoma cells in mature T cell-defective condition. Int J Oncol 13: 1217-1222, 1998.
12. Sugaya M, Tagawa M, Matsubara H et al: Induction of antitumor effect on human esophageal carcinoma cells by the retroviral expression of granulocyte macrophage-colony stimulating factor gene. Int J Oncol 12: 321-324, 1998.
13. Nakamura MC and Seaman WE: Ligand interactions by activating and inhibitory Ly-49 receptors. Immunol Rev 181: 138-148, 2001.
14. Ugai S, Shimozato O, Kawamura K, Wang Y-Q, Yamaguchi T, Saisho H, Sakiyama S and Tagawa M: Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther 10: 187-192, 2003.
15. Wang Y-Q, Ugai S, Shimozato O, Yu L, Kawamura K, Yamamoto H, Yamaguchi T, Saisho H and Tagawa M: Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells. Int J Cancer 105: 820-824, 2003.
16. Cua DJ, Sherlock J, Chen Y et al: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748, 2003.
17. Kato K, Shimozato O, Hoshi K, Wakimoto H, Hamada H, Yagita H and Okumuira K: Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci USA 93: 9085-9089, 1996.